Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS

Bibliographic Details
Main Authors:	Clark, A, Desai, M, Cull, C, Horton, V, Christie, MR, Bingley, P, Bonifacio, E, Levy, J, Holman, R
Format:	Conference item
Published:	2005

Similar Items

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
by: Desai, M, et al.
Published: (2007)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
by: Mehta, Z, et al.
Published: (1999)

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
by: Desai, M, et al.
Published: (2004)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
by: Turner, R, et al.
Published: (1997)

Susceptibility effects of variation at the IDDM2 (Insulin-gene) locus in latent autoimmune diabetes in adults (LADA).
by: Desai, M, et al.
Published: (2003)

Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
by: Chang, T, et al.
Published: (2013)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
by: Stagg, C, et al.
Published: (2010)

AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
by: N. V. Piven, et al.
Published: (2014-07-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
by: Davis, T, et al.
Published: (2005)

SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
by: Stagg, C, et al.
Published: (2009)

Genetic and immunological characterisation of patients with latent autoimmune diabetes in adults (LADA)
by: Desai, M, et al.
Published: (2005)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
by: Muzaimi, M, et al.
Published: (2004)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

Editorial: Latent Autoimmune Diabetes in Adults (LADA)
by: Richard David Leslie
Published: (2022-08-01)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

Ataxia associated with anti-glutamic acid decarboxylase antibodies
by: E. P. Nuzhnyi, et al.
Published: (2020-10-01)

Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)

Association of polymorphism rs7903146 gene TCF7L2 with low concentrations of autoantibodies in latent autoimmune diabetes of adults (LADA)
by: Iuliia V. Silko, et al.
Published: (2016-07-01)

Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA)
by: Horton, V, et al.
Published: (2001)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
by: Bottazzo, G, et al.
Published: (2005)

Risk factors for neuropathy in UKPDS
by: Stratton, I, et al.
Published: (2004)

Latvijas kultūras un mākslas sovetizācija pirmajā padomju okupācijas gadā: 1940. gada jūnijs – 1941. gada jūnijs
by: Aivars Stranga
Published: (2018-12-01)

Latvijas kultūras un mākslas sovetizācija pirmajā padomju okupācijas gadā: 1940. gada jūnijs – 1941. gada jūnijs
by: Aivars Stranga
Published: (2019-08-01)

Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes
by: Salem, S.D., et al.
Published: (2014)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
by: Matthews, DR, et al.
Published: (1998)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
by: Wright, A, et al.
Published: (1998)

Purification and characterization of glutamate decarboxylase from Aspergillus oryzae NSK
by: Lee, Audrey Ying Yeng
Published: (2014)

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
by: Antozzi, C, et al.
Published: (2005)

Neurological manifestations of glutamic acid decarboxylase autoimmunity in Indian patients
by: Meena Thevarkalam, et al.
Published: (2023-01-01)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
by: Levy, J, et al.
Published: (1993)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
by: Price, H, et al.
Published: (2007)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
by: Levy, J, et al.
Published: (1993)